vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and VinFast Auto Ltd. (VFS). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $718.6M, roughly 1.5× VinFast Auto Ltd.). VinFast Auto Ltd. runs the higher net margin — -2.8% vs -127.8%, a 125.0% gap on every dollar of revenue.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
VinFast Auto Ltd. is a Vietnamese multinational automotive company founded by Vingroup, one of the largest private conglomerates in Vietnam that was founded by Phạm Nhật Vượng.
PRGO vs VFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $718.6M |
| Net Profit | $-1.4B | $-20.0M |
| Gross Margin | 32.6% | — |
| Operating Margin | -116.0% | -96.1% |
| Net Margin | -127.8% | -2.8% |
| Revenue YoY | -2.5% | — |
| Net Profit YoY | -3093.9% | — |
| EPS (diluted) | $-10.23 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $718.6M | ||
| Q2 25 | $1.1B | $663.0M | ||
| Q1 25 | $1.0B | $656.5M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $511.6M | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | $302.6M |
| Q4 25 | $-1.4B | — | ||
| Q3 25 | $7.5M | $-20.0M | ||
| Q2 25 | $-8.4M | $-51.8M | ||
| Q1 25 | $-6.4M | $-26.1M | ||
| Q4 24 | $-44.4M | — | ||
| Q3 24 | $-21.0M | $-10.4M | ||
| Q2 24 | $-108.4M | — | ||
| Q1 24 | $2.0M | $-618.3M |
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
| Q4 25 | -116.0% | — | ||
| Q3 25 | 7.0% | -96.1% | ||
| Q2 25 | 4.3% | -79.0% | ||
| Q1 25 | 4.5% | -74.0% | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 7.4% | -65.9% | ||
| Q2 24 | -2.5% | — | ||
| Q1 24 | -5.1% | -139.4% |
| Q4 25 | -127.8% | — | ||
| Q3 25 | 0.7% | -2.8% | ||
| Q2 25 | -0.8% | -7.8% | ||
| Q1 25 | -0.6% | -4.0% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -1.9% | -2.0% | ||
| Q2 24 | -10.2% | — | ||
| Q1 24 | 0.2% | -204.3% |
| Q4 25 | $-10.23 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.32 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.79 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | — |
| Total Assets | $8.5B | $183.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $432.1M | $8.8M | ||
| Q2 25 | $454.2M | $650.0M | ||
| Q1 25 | $409.9M | $2.4M | ||
| Q4 24 | $558.8M | — | ||
| Q3 24 | $1.5B | $1.9M | ||
| Q2 24 | $542.8M | — | ||
| Q1 24 | $658.5M | $3.0M |
| Q4 25 | $2.9B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | $-7.2B | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.7B | — |
| Q4 25 | $8.5B | — | ||
| Q3 25 | $10.1B | $183.2M | ||
| Q2 25 | $10.1B | $7.2B | ||
| Q1 25 | $9.8B | $158.2M | ||
| Q4 24 | $9.6B | — | ||
| Q3 24 | $11.2B | $151.8M | ||
| Q2 24 | $10.4B | — | ||
| Q1 24 | $10.6B | $145.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | — |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | — | ||
| Q3 25 | $51.7M | — | ||
| Q2 25 | $75.9M | — | ||
| Q1 25 | $-64.5M | — | ||
| Q4 24 | $312.6M | — | ||
| Q3 24 | $42.2M | — | ||
| Q2 24 | $9.5M | — | ||
| Q1 24 | $-1.4M | — |
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.89× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
VFS
| Sales of vehicles | $662.9M | 92% |
| Sales of spare parts and components | $41.3M | 6% |
| Revenue from leasing activities | $12.3M | 2% |
| Finance income | $2.4M | 0% |
| Rendering of services | $1.2M | 0% |
